Auxly Cannabis Group Inc
TSX:XLY
Auxly Cannabis Group Inc
TSX:XLY
Price:
0.125
CAD
-3.85%
Market Closed
Market Cap:
CA$168.6m
Relative Value
The Relative Value of one
XLY
stock under the Base Case scenario is
0.105
CAD.
Compared to the current market price of 0.125 CAD,
Auxly Cannabis Group Inc
is
Overvalued by 16%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
XLY
Relative Value
Base Case
0.105
CAD
Overvaluation 16%
Multiples Across Competitors
XLY Competitors Multiples
Auxly Cannabis Group Inc Competitors
Auxly Cannabis Group Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Auxly Cannabis Group Inc
TSX:XLY
|
175.3m CAD | 1.2 | 3.7 | 5.3 | 7.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
992.9B USD | 15.2 | 48.1 | 32.4 | 34.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
575.5B USD | 6.1 | 21.5 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
282.2B CHF | 4.6 | 30 | 12.7 | 14.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.1B CHF | 5.3 | 21.2 | 13.1 | 16.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.7B GBP | 5.1 | 31.7 | 15.1 | 22.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
291.1B USD | 4.5 | 16 | 10 | 11.7 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.6 | 13.8 | 10.1 | 11.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.9B USD | 2.5 | 19.8 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.2B USD | 2.6 | 17.5 | 6.8 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
